Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Corixa Corporation

Corixa is a developer of immunotherapeutics with a commitment to treating and preventing autoimmune disease, cancer and infectious disease by understanding and directing the immune system. Corixa is focused on immunotherapeutic products and has a broad technology platform enabling both fully integrated vaccine design and the use of its separate, proprietary product components on a standalone basis. Corixa currently has 16 programs in clinical development and 22 programs in preclinical development, including its most advanced product candidate, BEXXAR®, a monoclonal antibody conjugated to a radioisotope.


Contact Details:
1124 Columbia Street Suite 200
Seattle
Washington
98104
United States of America
Tel:206 754 5711
Fax:206 754 5715
Email:info@corixa.com
WWW:

www.corixa.com/




Loading...

Recent Publications by Corixa Corporation:

Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys.
The development of a vaccine for tuberculosis requires a combination of...
28th March, 2009
Corixa Corporation, Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2301-6. Epub 2009 Feb 2.
DOI Direct Link
Variable expression of immunoreactive surface proteins of Propionibacterium acnes.
Despite accumulating data implicating Propionibacterium acnes in a variety...
28th March, 2007
Corixa Corporation, Infectious Disease Research Institute, Seattle, WA Microbiology. 2006 Dec;152(Pt 12):3667-81.
DOI Direct Link
Characterization of preexisting humoral immunity specific for two cancer-testis antigens overexpressed at the mRNA level in non-small cell lung cancer.
In order to establish a rationale for immunotherapy for lung cancer, we...
16th May, 2006
Department of Immunology, Antigen Discovery of Corixa Corporation, Cancer Immun. 2006 Feb 10;6:3.
VSGP/F-spondin: a new ovarian cancer marker.
The discovery of genes that are overexpressed in ovarian cancers provides...
27th September, 2005
Corixa Corporation, Tumour Biol. 2005 Sep-Oct;26(5):245-57. Epub 2005 Aug 9.
DOI Direct Link
Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.
Monoclonal antibodies have begun to show great clinical promise for the...
15th September, 2005
Antigen Discovery and Preclinical Biology, Corixa Corporation, Seattle, Cancer Res. 2005 Jul 15;65(14):6425-34.
DOI Direct Link

View more Corixa Corporation research publications.

Press Releases on Corixa Corporation:

BioPortfolio Logo
Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences 12th October, 2009 Takeda San Francisco, Inc.
SAN FRANCISCO, Oct. 12 /PRNewswire/ -- Takeda San Francisco, Inc. announced today that Michael Buckley, Ph.D., has joined the company as vice president of process sciences. Dr. Buckley will be
Patent Issued Related to Prometheus Proprietary Test CBir1 Antigen Test Included in Diagnostic for Inflammatory Bowel Disease 21st August, 2008 Prometheus Laboratories Inc.
SAN DIEGO, Aug. 21 /PRNewswire/ -- Prometheus Laboratories Inc. announced the issuance of U.S. Patent No. 7,361,733, "Compositions and Methods for the Therapy and Diagnosis of Inflammatory
Ganymed Announces License Of Wt1 Immunotherapy Rights By Corixa And Kirin 1st January, 1970 Ganymed
Ganymed Announces License Of Wt1 Immunotherapy Rights By Corixa And Kirin Mainz, Germany (June 08, 2004) - Ganymed Pharmaceuticals AG, Mainz, Germany, announced today that Corixa Corporation

BioNews Results for Corixa Corporation:

Trubion Pharmaceuticals, Inc. Announces Transition in Company Leadership
Pharma Live:  Nov 22 2009 3:01PM Matching: corixa
Trubion Pharmaceuticals, Inc. Announces Transition in Company Leadership
Montana's News Station:  Nov 17 2009 7:25AM Matching: corixa
Trubion Pharmaceuticals, Inc. Announces Transition in Company Leadership
TickerTech.com:  Nov 17 2009 2:41AM Matching: corixa
Trubion Pharmaceuticals, Inc. Announces Transition in Company Leadership
Reuters:  Nov 16 2009 10:57PM Matching: corixa
Trubion Pharmaceuticals, Inc. Announces Transition in Company Leadership
Street Insider:  Nov 16 2009 9:11PM Matching: corixa
Promote your company here: BioNewsCast - Press Release Distribution

View more Corixa Corporation news.

Corixa Corporation Clinical Trials:

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement

Corixa Corporation Patents:

US Patent No.Title
6977069 Fusion proteins of Mycobacterium tuberculosis antigens and their uses
7087713 Compounds and methods for diagnosis and immunotherapy of tuberculosis
7115272 Compositions and methods for WT1 specific immunotherapy
7122196 Compounds and methods for diagnosis of tuberculosis
7129219 Immunoeffector compounds

View more Corixa Corporation patents.

Corixa Corporation (CRXA) Financial information Links from Barchart

CRXA Quote from from Barchart.com
CRXA Chart from from Barchart.com
CRXA Profile from from Barchart.com
CRXA Opinion from from Barchart.com

View more Corixa Corporation finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 28 individuals from Corixa Corporation using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1009 times since April 2007, the link to the organisation's website has been followed 220 times

Recent Search Terms used to find this page: corixa | Corixa 2009 | Corixa 2009 | Corixa Corporation | corixa | corixa corporation | Corixa Corporation | Corixa | corixa tb vaccine | corixa corporation | .

Search for more companies in Seattle

Search for more companies in Washington



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Corixa Corporation

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.